ÐÂÎŶ¯Ì¬
ÔÚÕæºËϸ°ûÖУ¬Ö¬ÖÊÔÚÉúÎïĤÉϵÄÂþÑܾßÓÐ²î³Ø³ÆÐÔ¡£Ïêϸ¶øÑÔ£¬ÇÊÌÇÖ¬¡¢ÇÊÁ×Ö¬ºÍÁ×Ö¬õ£µ¨¼îµÈÖ÷ÒªÂþÑÜÔÚϸ°ûĤÍâ²à£¬¶ø°±»ùÁ×Ö¬ÈçÁ×Ö¬õ£ÒÒ´¼°·ºÍÁ×Ö¬õ£Ë¿°±ËᣨPS£©Ö÷ÒªÂþÑÜÔÚϸ°ûÄڲࡣPSÊÇÒ»ÀàÓɳ¤Á´Ö¬·¾Ëᣬ¸ÊÓ͹ǼܺÍÁ×֬ͷ»ù×é³ÉµÄ»¯ºÏÎ½á¹¹Í¨Ê½¼ûÏÂͼ£º
ͼһ Á×Ö¬õ£Ë¿°±ËáµÄ½á¹¹Í¨Ê½
Á×Ö¬õ£Ë¿°±Ëá×÷ÎªÕæºËϸ°ûÖк¬Á¿×î¸ßµÄÒõÀë×ÓÁ×Ö¬£¬Ô¼Õ¼Ï¸°û×ÜÖ¬ÖʵÄ10%£¬¶Ôµ÷ÖÎϸ°ûĤµÄÁ÷¶¯ÐÔºÍͨ͸ÐÔ¾ßÓÐÒªº¦×÷Ó㬲¢ÇÒÄܼ¤»î¶àÖÖøÀàµÄ´úлºÍºÏ³É¡£±ðµÄ£¬PS¹ØÓÚ¸ÄÉÆÉñ¾Ï¸°û¹¦Ð§£¬µ÷ÀíÉñ¾ÐźÅת´ïºÍÔö½ø´óÄÔÓ°Ïó¹¦Ð§¾ßÓÐÆð¾¢Ó°Ïì¡£
ÈËÌåÄܹ»×ÔÖ÷ºÏ³ÉPS£¬Í¬Ê±Ò²¿ÉÒÔͨ¹ýʳÎïµÈÍⲿ;¾¶»ñÈ¡¡£ÔÚ´óÄÔÉñ¾Ï¸°ûµÄĤ½á¹¹ÖУ¬PSµÄŨ¶ÈÓÈΪͻ³ö£¬ÆäÔÚĤÉÏµÄ²î³Ø³ÆÂþÑܹØÓÚά³Öϸ°ûÕý³£ÐÄÀí¹¦Ð§ÖÁ¹ØÖ÷Òª¡£
ÔÚ¿µ½¡Ï¸°ûÖУ¬PS¼ÓÈëÄýѪÀú³Ì£¬³É¼¡Ï¸°ûÈÚºÏÒÔ¼°TÁܰÍϸ°û»î»¯µÈ¶àÖÖÐÄÀí¹¦Ð§¡£ËüÊÇϸ°ûµòÍöµÄÆæÒìÌØÕ÷£¬Äܹ»ÎªÏ¸°ûµòÍöÌṩ¿Éʶ±ðºÍ¿ÉÇø·ÖµÄÐźš£ÔÚ¿µ½¡Ï¸°ûÖУ¬PSλÓÚϸ°ûĤÄڲ࣬¶øµ±Ï¸°û×îÏȵòÍöʱ£¬PS»á´Óϸ°ûĤµÄÄÚ²à·×ªµ½Ï¸°ûĤµÄÍâò£¬Ì»Â¶ÓÚ°ûÍâÇéÐÎÖУ¬´Ó¶ø×÷ΪµòÍöϸ°ûµÄÐźţ¬±»¾ÞÊÉϸ°ûÖбí´ïµÄPSÊÜÌåʶ±ð²¢É¨³ý¡£
ÔÚÖ×Áö΢ÇéÐÎÖУ¬PSÔÚÖ×Áöϸ°ûºÍÃâÒßϸ°ûÍâòµÄ̻¶ÓëÃâÒßÒÖÖÆºÍÖ×ÁöÉú³¤µÄÔö½øÓйأ¬Òò´Ë£¬PSÔÚϸ°ûĤÉϵÄλÖùØÓÚϸ°ûµÄ´æ»î¡¢Éú³¤¡¢ÔöÖ³ÒÔ¼°°©Ö¢Ïà¹ØÖ¢×´¾ßÓÐÖØ´óÒâÒå¡£
°ÐÏòPS±»ÒÔΪÊǰ©Ö¢ÖÎÁƵÄÒ»ÖÖÓÐǰ;µÄÕ½ÂÔ£¬½üÄêÀ´£¬¿ÆÑ§¼ÒÃÇÒѾ¿ª·¢³ö¶àÖÖ°ÐÏòPSµÄÒ©ÎÓÃÓÚ°©Ö¢ÖÎÁÆ¡£ÔÚÁÙ´²ÊÔÑéÖУ¬°ÍάÍ×Îôµ¥¿¹×÷Ϊ¼òµ¥Ò©Îï»òÓëÆäËû¹Å°åÖÎÁÆÒªÁìÍŽáÓ¦Óã¬Òѱ»Ö¤ÊµÔÚÖÎÁƷΰ©¡¢¸Îϸ°û°©¡¢ÈéÏÙ°©¡¢ÒÈÏÙ°©ºÍÆäËûʵÌåÁö·½Ãæ¾ßÓÐÁÆÐ§£¬²¢ÇÒ±¬·¢µÄ¸±×÷ÓÃÏà¶Ô½ÏÉÙ¡£±ðµÄ£¬°ÍάÍ×Îôµ¥¿¹ÓëË÷À·ÇÄáÍŽáÖÎÁƸÎϸ°û°©£¬ÒÔ¼°Ó뼪Î÷Ëû±õÍŽáÖÎÁÆÒÈÏÙ°©£¬Ò²Õ¹ÏÖ³öÁËÏÔÖøµÄÖÎÁÆÐ§¹û¡£ÕâЩ·¢Ã÷Ϊ°©Ö¢ÖÎÁÆ¿ª·¢ÁËеĿÉÄÜÐÔ¡£³ý´ËÖ®Í⣬¿¹ÌåżÁªÒ©Î֬ÖÊÌåÔØÌåÒ²ÊÇDZÔÚµÄÓÃÓÚÖÎÁÆÖ×ÁöµÄ°ÐÏòPSÕ½ÂÔ¡£
ÔÚÉñ¾ÉúÎïѧÁìÓò£¬PSÔÚÉñ¾Ï¸°ûĤÖк¬Á¿¸»ºñ£¬¶ÔÉñ¾Ï¸°ûµÄ´æ»î¡¢ÐÞ¸´ºÍ¹¦Ð§Ê©Õ¹ÖÁ¹ØÖ÷Òª¡£PSÔÚÖÐÊàÉñ¾ÏµÍ³ÖеÄÖ÷Òª×÷ÓðüÀ¨Ôö½ø¶à°Í°·µÄÊÍ·Å£¬ÔöÌíÉñ¾µÝÖÊÒÒõ£µ¨¼îµÄÌìÉú£¬ÌáÉýÄÔÆÏÌÑÌÇ´úлЧÂÊ£¬½µµÍÇ⻯¿ÉµÄËÉˮƽ£¬ÒÔ¼°ÔöÇ¿Éñ¾Éú³¤Òò×ӵĻîÐԵȡ£Òò´Ë£¬PSÔÚ¶àÖÖÖÐÊàÉñ¾ÏµÍ³¼²²¡ÖÐÊÎÑÝ×ÅÖ÷Òª½ÇÉ«£¬Õ⺸ÇÁ˰¢¶û´Äº£Ä¬²¡¡¢ÅÁ½ðɲ¡¡¢ÒÖÓôÖ¢¡¢È±ÑªÐÔÖз硢×Ô±ÕÖ¢¡¢×¢ÖØÁ¦È±ÏݶදÕϰ¡¢¾«ÉñÆÆËéÖ¢ÒÔ¼°¼¹ËèËðÉ˵Ȳ¡Ö¢¡£
Ëæ×ÅÄêËêÔöÌí£¬´óÄÔÖе¨¹Ì´¼Ë®Æ½ÉÏÉý¶øÁ×Ö¬õ£Ë¿°±ËᣨPS£©º¬Á¿Ï½µ£¬Õâ»áµ¼Ö´óÄÔϸ°ûÄÚø»îÐÔÏ÷Èõ¡¢Ï¸°ûÔËÊäÄÜÁ¦½µµÍÒÔ¼°Í»´¥ÅþÁ¬ïÔÌ£¬×îÖÕÒýÆðÓ°ÏóÁ¦¼õÍË¡£°¢¶û´Äº£Ä¬²¡£¨AD£©ÊÇÒ»ÖÖÂýÐÔÉñ¾ÍËÐÐÐÔ¼²²¡£¬ÊÇÍíÄê³Õ´ô֢ϵÁÐ×î³£¼ûµÄÒ»ÖÖ¼²²¡¡£Ïà¹ØÁÙ´²Ñо¿Åú×¢£¬ÖðÈÕÈý´Î£¬Ã¿´ÎÔö²¹100ºÁ¿ËPS£¬Ò»Á¬·þÓÃ12ÖÜ£¬ÄÜÏÔÖø¸ÄÉÆAD»¼ÕßµÄÈÏÖª¹¦Ð§ºÍÓ°ÏóÁ¦¡£Í¬Ê±£¬½«300ºÁ¿ËPSÓë240ºÁ¿ËPAÍŽáʹÓã¬Ò²ÏÔʾ³ö¶Ô¸ÄÉÆ»¼ÕßÇéÐ÷ºÍÒ»Ñùƽ³£ÉúÑÄÖÊÁ¿µÄÆð¾¢Ð§¹û¡£
×¢ÖØÁ¦È±ÏݶදÕϰ£¨ADHD£©¼´¶à¶¯Ö¢ÊÇÒ»ÖÖÉñ¾·¢ÓýÕϰ£¬ÌØÕ÷ÌåÏÖÎª×¢ÖØÁ¦²»¼¯ÖУ¬Ò×¼¤¶¯£¬Ì«¹ý»îÔ¾µÈ¡£ÏÖÔÚÓÃÓÚÖÎÁÆADHDµÄÒ©Î²¢²»ÊÇËùÓжùͯ¶¼ÄÜÓÐÏìÓ¦»òÄÍÊÜ£¬HirayamaÍŶÓÁÙ´²Ñо¿·¢Ã÷£¬Ò»Á¬2¸öÔÂÌìÌìÔö²¹200 ºÁ¿Ë PS£¬¿ÉÒÔÏÔÖø¸ÄÉÆADHD¶ùͯµÄÕûÌåÖ¢×´ºÍ¶ÌÆÚÌý¾õÓ°Ïó¡£
Á×Ö¬õ£Ë¿°±ËáÊÇÒ»ÖÖÔÚÈËÌåÄÚ×ÔÈ»±£´æµÄÁ×Ö¬ÓªÑøËØ£¬ÓÈÆäÔÚ´óÄÔ¡¢·Î¡¢ÐÄÔà¡¢¸ÎÔàºÍ¹Ç÷À¼¡µÈ´úл»îÔ¾µÄÆ÷¹ÙÖк¬Á¿¸»ºñ¡£PSÄÜÓë¶àÖÖÂѰ×ÖÊÍŽᣬ¼ÓÈëµ÷¿Ø¶àÖÖÉúÎïÀú³Ì£¬°üÀ¨Ã¸µÄ¼¤»î¡¢Ï¸°ûµÄµòÍöÒÔ¼°Éñ¾ÐźŵÄת´ïµÈ¡£Ôö²¹PS²»µ«¹ØÓÚÖÎÁÆÖÐÊàÉñ¾ÏµÍ³¼²²¡Èç°¢¶û´Äº£Ä¬²¡ÓÐÆð¾¢×÷Ó㬻¹ÔÚ°©Ö¢ÖÎÁÆÖÐÏÔʾ³öDZÁ¦£¬»¹ÆÕ±éÓ¦ÓÃÓÚÓªÑøÑ§ÁìÓò£¬ÀýÈç¸ÄÉÆÇéÐ÷ºÍ¿µ½¡×´Ì¬£¬Ìá¸ßÈÏÖª¹¦Ð§ºÍÔ˶¯ÌåÏÖ£¬»º½â¼¡ÈâËáÍ´£¬¸ÄÉÆË¯Ãߵȡ£
ThorntonÍŶӵÄÑо¿Ð§¹ûÅú×¢£¬Ôö²¹PSÄÜÓÐÓøÄÉÆÄêÇ῵½¡´óѧÉúµÄÈÏÖª¹¦Ð§£¬ÏêϸÌåÏÖΪÅÌËãËÙÂÊÌá¸ß20%£¬¹ýʧ×ÜÁ¿ïÔÌ39%£¬×¼È·ÅÌËã×ÜÁ¿Ìá¸ß13%¡£
±ðµÄ£¬PS»¹Äܹ»ÔöÇ¿¸öÌåµÄ¿¹Ñ¹ÄÜÁ¦£¬²¢¼õ»ºÌ«¹ýÔ˶¯´øÀ´µÄÐÄÀíѹÁ¦¡£Â½æ¯æ¯ºÍ°²ÑàµÈÑо¿Õߵķ¢Ã÷ÏÔʾ£¬¸ßˮƽÉä»÷ÔË·¢¶¯ÔÚ½ÇÖðǰÔö²¹800mg/dµÄPS£¬Äܹ»Í¨¹ý½µµÍƤÖÊ´¼Ë®Æ½¡¢¸ÄÉÆÐľ³ºÍ˯ÃßÖÊÁ¿£¬´Ó¶øÌáÉýÐÄÀíÓ¦¼¤Ë³Ó¦ÄÜÁ¦¡£
×ÛÉÏËùÊö£¬PSÔÚҽѧºÍÓªÑøÑ§ÁìÓòÓÐ×ÅÆÕ±éµÄÓ¦Óã¬È»¶ø£¬´Ó´ó¶¹»ò¶¯ÎïÔàÆ÷ÖкÜÄÑ»ñµÃ¼òµ¥ÇҸߴ¿¶ÈµÄPS£¬¼òµ¥»¯Ñ§½á¹¹µÄ¸ß´¿¶ÈPSͨ³£ÐèÒª»¯Ñ§ºÏ³É·¨Éú²ú»ñµÃ¡£ÎÒÃǹ«Ë¾Äܹ»Ïò¿ÆÑÐÊÂÇéÕßÌṩÖÖÖָߴ¿¶ÈµÄÁ×Ö¬õ£Ë¿°±Ëᣬ½Ó´ýÓÐÐèÇóµÄÅóÙÀ´µç´¹Ñ¯£¡
±íÒ» ²©Ô´¹ú¼ÊÉúÎï¿ÉÒÔÌṩµÄÏà¹Ø²úÆ·
²Î¿¼ÎÄÏ×£º
[1] Wang, J.; Yu, C.X.; Qi, J.X.; et al. The role of phosphatidylserine on the membrane in immunity and blood coagulation[J]. Biomark Res. 2022, 10, 4.
[2] Kay, J.G.; Fairn, G.D.; Distribution, dynamics and functional roles of phosphatidylserine within the cell[J]. Cell Commun Signal. 2019, 17, 126.
[3] Shlomovitz, I.; Speir, M.; Gerlic, M. Flipping the dogma-phosphatidylserine in non-apoptotic cell death[J]. Cell Commun Signal. 2019, 17, 139.
[4] Chang, W.G.; Fa, H.G.; Xiao, D.D.; Wang, J.X. Targeting phosphatidylserine for Cancer therapy: prospects and challenges[J]. Theranostics. 2020, 10, 9214-9229.
[5] ËÎÊçÁÁ, ¼ª°®¹ú. Á×Ö¬õ£Ë¿°±ËáµÄÖÐÊàÉñ¾×÷ÓÃ[J]. ÖйúÉú»¯Ò©ÎïÔÓÖ¾. 2006, 27, 117-119.
[6] Ma, X.H.; Li, X.J.; Miao, Z.G.; et, al. Phosphatidylserine, inflammation, and central nervous system diseases[J]. Front. Aging Neurosci. 2022, 14, 975176.
[7] Hirayama, S.; Terasawa, K.; J?ger, R.; et al. The effect of phosphatidylserine administration on memory and symptoms of attention- deficit hyperactivity disorder: a randomised, double-blind, placebo- controlled clinical trial[J]. J. Hum. Nutr. Diet. 2013, 27, 284-291.
[8] Starks, M.A.; Starks, S.L.; J?ger, R.; et al. The effects of phosphatidylserine on endocrine response to moderate intensity exercise[J]. J Int Soc Sports Nutr. 2008, 5, 11.
[9] Parker, A.G.; Gordon, J.; Kreider, R.D.; et al. The effects of IQPLUS Focus on cognitive function, mood and endocrine response before and following acute exercise[J]. J Int Soc Sports Nutr. 2011, 8, 16.
[10] J?ger, R.; Purpura, M.; Herwegen, H.; et al. The effect of phosphatidylserine on golf performance[J]. J Int Soc Sports Nutr. 2007, 4, 23.
[11] ½½¿½¿, °²Ñà, Ðíèª, ³ÂÓÀÇ¿. Á×Ö¬õ£Ë¿°±Ëá¶ÔÉä»÷ÔË·¢¶¯ÐÄÀíÓ¦¼¤Ë³Ó¦ÄÜÁ¦¼°ÄÔÄÚÉñ¾µÝÖʼ¤»îˮƽµÄÓ°Ïì[J]. ÓªÑøÑ§±¨. 2019, 41, 439-443.